100 related articles for article (PubMed ID: 2591302)
1. Efficacy and safety of cefotetan in the treatment of complicated urinary tract infections: clinical experience in a selective and single study.
Gesualdo L; Quarto M; Viggiani N; Germinario C; Barbuti S; Schena FP
Drugs Exp Clin Res; 1989; 15(6-7):309-13. PubMed ID: 2591302
[TBL] [Abstract][Full Text] [Related]
2. Bacteriological and clinical evaluation of cefotetan in the treatment of severe infections in hospitalized patients.
Romanelli G; Agabiti-Rosei E; Giustina A; Guarnera L; Muiesan ML; Pelizzari G; Turano A
Drugs Exp Clin Res; 1988; 14(6):411-7. PubMed ID: 3215108
[TBL] [Abstract][Full Text] [Related]
3. [Double-blind comparative clinical study of cefpiramide (SM-1652) and cefsulodin on complicated urinary tract infections due to P. aeruginosa].
Kawamura N; Ohkoshi M; Okada K; Kumamoto Y; Miyamoto S; Niijima T; Kishi Y; Nishimura Y; Saito I; Yuge J
Hinyokika Kiyo; 1983 Sep; 29(9):1147-88. PubMed ID: 6375316
[TBL] [Abstract][Full Text] [Related]
4. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
[TBL] [Abstract][Full Text] [Related]
5. [Cefotetan vs ceftriaxone: clinical and bacteriological efficacy in complicated forms of urinary tract infection].
D'Amato C; De Carli G; Leoni GC; Bordi E; Carvelli C; Colaiacomo M; Struglia C; Visco G
Clin Ter; 1989 Mar; 128(5):347-50. PubMed ID: 2524322
[TBL] [Abstract][Full Text] [Related]
6. A sequential study of intravenous and oral fleroxacin in the treatment of complicated urinary tract infection.
Gelfand MS; Simmons BP; Craft RB; Grogan J; Amarshi N
Am J Med; 1993 Mar; 94(3A):126S-130S. PubMed ID: 8452168
[TBL] [Abstract][Full Text] [Related]
7. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051
[TBL] [Abstract][Full Text] [Related]
8. Single-dose cefotetan for urinary tract infection.
Sanderson PJ
Pharmatherapeutica; 1985; 4(5):332-4. PubMed ID: 3906676
[TBL] [Abstract][Full Text] [Related]
9. Fleroxacin versus ofloxacin in patients with complicated urinary tract infection: a controlled clinical study.
Naber KG; Sigl G
Am J Med; 1993 Mar; 94(3A):114S-117S. PubMed ID: 8452166
[TBL] [Abstract][Full Text] [Related]
10. [Clinical efficacy of tosufloxacin on the patients with urinary tract infections].
Yoshida K; Kobayashi N; Saitoh H; Negishi T; Yamada T; Watanabe T; Kawakami S; Tari K; Satake I; Ozawa K
Hinyokika Kiyo; 1992 Jan; 38(1):129-34. PubMed ID: 1546562
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience in the treatment of complicated urinary tract infection with different doses of moxalactam (lamoxactam).
Hautmann R; Pranada F; Ahlert G
Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):209-12. PubMed ID: 6222995
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of the combination of carumonam and cefotiam in the treatment of complicated urinary tract infection].
Sonoda T; Nakano E; Seguchi T; Yano H; Kuroda H; Ihara Y; Kishimoto T; Takatera H; Mizutani S; Iwao N
Hinyokika Kiyo; 1991 Feb; 37(2):203-9. PubMed ID: 2048503
[TBL] [Abstract][Full Text] [Related]
13. [Clinical experience with cefmenoxime (CMX) in complicated urinary tract infections].
Minami Y; Kanda S; Matsuo R; Sakai H; Kamemoto H; Hisamatsu A; Maruta N; Johdai A; Shimomae H; Watanabe Y
Hinyokika Kiyo; 1985 Jun; 31(6):1077-84. PubMed ID: 3864365
[TBL] [Abstract][Full Text] [Related]
14. [Concomitant therapy with cefmenoxime and cefsulodin for refractory complicated urinary tract infection (especially caused by Pseudomonas aeruginosa)].
Ishigami J; Fujii A; Harada M; Arakawa S; Umezu K; Kawabata G; Kataoka N; Kamidono S; Miyazaki S; Takasaki N
Hinyokika Kiyo; 1986 May; 32(5):779-88. PubMed ID: 3463188
[TBL] [Abstract][Full Text] [Related]
15. Cefotetan in complicated urinary tract infections--clinical experience.
Hautmann R; Pranada F; Pusztai-Markos Z
J Antimicrob Chemother; 1983 Jan; 11 Suppl():223-6. PubMed ID: 6573321
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of aztreonam for complicated urinary tract infection].
Moriguchi R; Yamagoshi T; Nagakubo I; Aoki S
Hinyokika Kiyo; 1985 Sep; 31(9):1675-80. PubMed ID: 4083224
[TBL] [Abstract][Full Text] [Related]
17. [Clinical study of cefotetan in complicated urinary tract infections].
Suzuki T; Soma H; Tazawa H; Hamada W; Sugihara K; Fukushi M; Eba H
Hinyokika Kiyo; 1987 Nov; 33(11):1917-20. PubMed ID: 3481955
[TBL] [Abstract][Full Text] [Related]
18. [Clinical efficacy of aztreonam in patients with complicated urinary tract infections].
Yoshida K; Uchijima Y; Kobayashi N; Suwata J; Nakame Y; Saitoh H; Negishi T; Yamada T; Kageyama Y; Kura N
Hinyokika Kiyo; 1988 Dec; 34(12):2225-32. PubMed ID: 3071130
[TBL] [Abstract][Full Text] [Related]
19. [The effectiveness of enoxacin for the treatment of complicated urinary tract infection].
Germinario C; Quarto M; Viggiani N; Schena FP
Riv Eur Sci Med Farmacol; 1992; 14(5):347-51. PubMed ID: 1308966
[TBL] [Abstract][Full Text] [Related]
20. Comparison of single-dose cefotetan and multidose cefoxitin as intravenous prophylaxis in elective, open biliary tract surgery: a multicentre, double-blind, randomized study.
Lapointe RW; Roy AF; Turgeon PL; Lewis RT; Dagenais MH; Joly JR; Scudamore CH; Roy PD; Conly JM; Syrotuik J
Can J Surg; 1994 Aug; 37(4):313-8. PubMed ID: 8055389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
